345 related articles for article (PubMed ID: 21930178)
21. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.
Huang TL; Lee CT
J Psychiatr Res; 2006 Oct; 40(7):664-8. PubMed ID: 16386272
[TBL] [Abstract][Full Text] [Related]
22. WAIS-IV profile of cognition in schizophrenia.
Michel NM; Goldberg JO; Heinrichs RW; Miles AA; Ammari N; McDermid Vaz S
Assessment; 2013 Aug; 20(4):462-73. PubMed ID: 23443820
[TBL] [Abstract][Full Text] [Related]
23. Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Shimizu E; Hashimoto K; Iyo M
Neurosci Lett; 2014 Jul; 575():37-41. PubMed ID: 24861509
[TBL] [Abstract][Full Text] [Related]
24. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
25. Plasma and serum brain-derived neurotrophic factor (BDNF) levels and their association with neurocognition in at-risk mental state, first episode psychosis and chronic schizophrenia patients.
Heitz U; Papmeyer M; Studerus E; Egloff L; Ittig S; Andreou C; Vogel T; Borgwardt S; Graf M; Eckert A; Riecher-Rössler A
World J Biol Psychiatry; 2019 Sep; 20(7):545-554. PubMed ID: 29938562
[No Abstract] [Full Text] [Related]
26. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
[TBL] [Abstract][Full Text] [Related]
27. Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic patients with schizophrenia.
Kuo FC; Lee CH; Hsieh CH; Kuo P; Chen YC; Hung YJ
Psychiatry Res; 2013 Sep; 209(2):150-4. PubMed ID: 23219101
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
[TBL] [Abstract][Full Text] [Related]
29. Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Goto N; Yoshimura R; Kakeda S; Moriya J; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Korogi Y; Nakamura J
Hum Psychopharmacol; 2009 Dec; 24(8):639-45. PubMed ID: 19946939
[TBL] [Abstract][Full Text] [Related]
30. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
[TBL] [Abstract][Full Text] [Related]
31. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
Vinogradov S; Fisher M; Holland C; Shelly W; Wolkowitz O; Mellon SH
Biol Psychiatry; 2009 Sep; 66(6):549-53. PubMed ID: 19368899
[TBL] [Abstract][Full Text] [Related]
32. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder.
Oral E; Canpolat S; Yildirim S; Gulec M; Aliyev E; Aydin N
Brain Res Bull; 2012 Aug; 88(5):454-9. PubMed ID: 22498307
[TBL] [Abstract][Full Text] [Related]
33. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L
Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079
[TBL] [Abstract][Full Text] [Related]
34. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
[TBL] [Abstract][Full Text] [Related]
36. Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
Eker SS; Yavasci EO; Cangur S; Kirli S; Sarandol E
Acta Neuropsychiatr; 2014 Oct; 26(5):291-7. PubMed ID: 25241757
[TBL] [Abstract][Full Text] [Related]
37. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
[TBL] [Abstract][Full Text] [Related]
38. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
[TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
[TBL] [Abstract][Full Text] [Related]
40. Lower serum tropomyosin receptor kinase B levels in patients with schizophrenia.
Hung YY; Huang TL
Biomed J; 2013; 36(3):132-6. PubMed ID: 23806883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
